Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Johnson and Johnson
Colorcon
Express Scripts
AstraZeneca

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Apothecon Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.

There are three tentative approvals on APOTHECON drugs.

Summary for Apothecon
US Patents:0
Tradenames:78
Ingredients:47
NDAs:114

Drugs and US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 061655-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Apothecon PRINCIPEN ampicillin/ampicillin trihydrate CAPSULE;ORAL 062888-002 Mar 4, 1988 DISCN No No   Start Trial   Start Trial
Apothecon CEFADYL cephapirin sodium INJECTABLE;INJECTION 062724-001 Dec 23, 1986 DISCN No No   Start Trial   Start Trial
Apothecon DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride TABLET;ORAL 074051-004 Mar 31, 1993 DISCN No No   Start Trial   Start Trial
Apothecon OPHTHAINE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 008883-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Apothecon ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075583-002 Aug 22, 2000 DISCN No No   Start Trial   Start Trial
Apothecon CEFADYL cephapirin sodium INJECTABLE;INJECTION 050446-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 4,217,347   Start Trial
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-001 Approved Prior to Jan 1, 1982 3,819,635   Start Trial
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 4,105,776   Start Trial
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 4,217,347   Start Trial
Apothecon KLOTRIX potassium chloride TABLET, EXTENDED RELEASE;ORAL 017850-001 Approved Prior to Jan 1, 1982 4,140,756   Start Trial
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 4,105,776   Start Trial
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 4,105,776   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Boehringer Ingelheim
Express Scripts
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.